ID   E2F1_RAT                Reviewed;         432 AA.
AC   O09139;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-2015, sequence version 2.
DT   02-OCT-2024, entry version 155.
DE   RecName: Full=Transcription factor E2F1 {ECO:0000303|PubMed:20176812};
DE            Short=E2F-1 {ECO:0000303|PubMed:20176812};
GN   Name=E2f1 {ECO:0000303|PubMed:20176812, ECO:0000312|RGD:728892};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8673024;
RA   Hosokawa Y., Yang M., Kaneko S., Tanaka M., Nakashima K.;
RT   "Synergistic gene expressions of cyclin E, cdk2, cdk5 and E2F-1 during the
RT   prolactin-induced G1/S transition in rat Nb2 pre-T lymphoma cells.";
RL   Biochem. Mol. Biol. Int. 37:393-399(1995).
RN   [2]
RP   INTERACTION WITH CEBPA.
RX   PubMed=20176812; DOI=10.1128/mcb.01619-09;
RA   Zaragoza K., Begay V., Schuetz A., Heinemann U., Leutz A.;
RT   "Repression of transcriptional activity of C/EBPalpha by E2F-dimerization
RT   partner complexes.";
RL   Mol. Cell. Biol. 30:2293-2304(2010).
CC   -!- FUNCTION: Transcription activator that binds DNA cooperatively with DP
CC       proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in
CC       the promoter region of a number of genes whose products are involved in
CC       cell cycle regulation or in DNA replication. The DRTF1/E2F complex
CC       functions in the control of cell-cycle progression from G1 to S phase.
CC       E2F1 binds preferentially RB1 in a cell-cycle dependent manner. It can
CC       mediate both cell proliferation and TP53/p53-dependent apoptosis.
CC       Blocks adipocyte differentiation by binding to specific promoters
CC       repressing CEBPA binding to its target gene promoters. Directly
CC       activates transcription of PEG10. Positively regulates transcription of
CC       RRP1B. {ECO:0000250|UniProtKB:Q01094}.
CC   -!- ACTIVITY REGULATION: BIRC2/c-IAP1 stimulates its transcriptional
CC       activity. {ECO:0000250|UniProtKB:Q01094}.
CC   -!- SUBUNIT: Component of the DRTF1/E2F transcription factor complex. Forms
CC       heterodimers with DP family members. The E2F1 complex binds
CC       specifically hypophosphorylated RB1, the interaction represses E2F1-
CC       driven transcription. During the cell cycle, RB1 becomes phosphorylated
CC       in mid-to-late G1 phase, detaches from the DRTF1/E2F complex, rendering
CC       E2F transcriptionally active. Interacts with TRRAP, which probably
CC       mediates its interaction with histone acetyltransferase complexes,
CC       leading to transcription activation. Binds TOPBP1 and EAPP. Interacts
CC       with ARID3A. Interacts with TRIM28; the interaction inhibits E2F1
CC       acetylation through recruiting HDAC1 and represses its transcriptional
CC       activity. Interaction with KAT2B; the interaction acetylates E2F1
CC       enhancing its DNA-binding and transcriptional activity. Interacts with
CC       BIRC2/c-IAP1 (via BIR domains). The complex TFDP1:E2F1 interacts with
CC       CEBPA; the interaction prevents CEBPA binding to target genes promoters
CC       and represses its transcriptional activity. Interacts with RRP1B.
CC       Interacts with HCFC1. Interacts with KMT2E; the interaction is probably
CC       indirect and is mediated via HCFC1. Interacts with DCAF5 and L3MBTL3;
CC       the interaction requires methylation at Lys-183 and is necessary to
CC       target E2F1 for ubiquitination by the CRL4-DCAF5 E3 ubiquitin ligase
CC       complex (By similarity). {ECO:0000250|UniProtKB:Q01094,
CC       ECO:0000250|UniProtKB:Q61501}.
CC   -!- INTERACTION:
CC       O09139; P33568: Rb1; NbExp=2; IntAct=EBI-1211101, EBI-1162932;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q01094}.
CC   -!- PTM: Phosphorylated by CDK2 and cyclin A-CDK2 in the S-phase.
CC       Phosphorylation by CHEK2 stabilizes E2F1 upon DNA damage and regulates
CC       its effect on transcription and apoptosis. Phosphorylation at Ser-398
CC       by GSK3B promotes interaction with USP11, leading to its
CC       deubiquitination and stabilization. {ECO:0000250|UniProtKB:Q01094}.
CC   -!- PTM: Ubiquitinated via 'Lys-63'-linked ubiquitin, leading to its
CC       degradation. Deubiquitinated by USP11 following phosphorylation by
CC       GSK3B, promoting its stability. {ECO:0000250|UniProtKB:Q01094}.
CC   -!- PTM: Acetylation stimulates DNA-binding. Enhanced under stress
CC       conditions such as DNA damage and inhibited by retinoblastoma protein
CC       RB1. Regulated by KAP1/TRIM28 which recruits HDAC1 to E2F1 resulting in
CC       deacetylation (By similarity). {ECO:0000250|UniProtKB:Q01094}.
CC   -!- PTM: Methylation at Lys-183 by SETD7 promotes E2F1 ubiquitin-dependent
CC       proteasomal degradation. {ECO:0000250|UniProtKB:Q01094}.
CC   -!- SIMILARITY: Belongs to the E2F/DP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D63165; BAA09641.1; -; mRNA.
DR   RefSeq; NP_001094248.1; NM_001100778.1.
DR   AlphaFoldDB; O09139; -.
DR   SMR; O09139; -.
DR   IntAct; O09139; 1.
DR   STRING; 10116.ENSRNOP00000022428; -.
DR   PhosphoSitePlus; O09139; -.
DR   PaxDb; 10116-ENSRNOP00000022428; -.
DR   Ensembl; ENSRNOT00055046483; ENSRNOP00055038124; ENSRNOG00055026928.
DR   Ensembl; ENSRNOT00060042569; ENSRNOP00060035259; ENSRNOG00060024587.
DR   Ensembl; ENSRNOT00065043397; ENSRNOP00065035591; ENSRNOG00065025204.
DR   GeneID; 399489; -.
DR   KEGG; rno:399489; -.
DR   UCSC; RGD:728892; rat.
DR   AGR; RGD:728892; -.
DR   CTD; 1869; -.
DR   RGD; 728892; E2f1.
DR   VEuPathDB; HostDB:ENSRNOG00000016708; -.
DR   eggNOG; KOG2577; Eukaryota.
DR   HOGENOM; CLU_032091_0_1_1; -.
DR   InParanoid; O09139; -.
DR   OrthoDB; 1761at2759; -.
DR   Reactome; R-RNO-68911; G2 Phase.
DR   Reactome; R-RNO-69231; Cyclin D associated events in G1.
DR   PRO; PR:O09139; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000016708; Expressed in frontal cortex and 18 other cell types or tissues.
DR   ExpressionAtlas; O09139; baseline and differential.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0000228; C:nuclear chromosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0035189; C:Rb-E2F complex; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; ISO:RGD.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001216; F:DNA-binding transcription activator activity; ISS:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0043276; P:anoikis; ISO:RGD.
DR   GO; GO:0071398; P:cellular response to fatty acid; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IDA:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0000077; P:DNA damage checkpoint signaling; ISS:UniProtKB.
DR   GO; GO:0006351; P:DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0030900; P:forebrain development; ISO:RGD.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:RGD.
DR   GO; GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; ISO:RGD.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; ISS:UniProtKB.
DR   GO; GO:1990086; P:lens fiber cell apoptotic process; ISO:RGD.
DR   GO; GO:0048255; P:mRNA stabilization; ISO:RGD.
DR   GO; GO:0043392; P:negative regulation of DNA binding; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0070345; P:negative regulation of fat cell proliferation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0060252; P:positive regulation of glial cell proliferation; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0051726; P:regulation of cell cycle; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   CDD; cd14660; E2F_DD; 1.
DR   Gene3D; 6.10.250.540; -; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR015633; E2F.
DR   InterPro; IPR037241; E2F-DP_heterodim.
DR   InterPro; IPR032198; E2F_CC-MB.
DR   InterPro; IPR003316; E2F_WHTH_DNA-bd_dom.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR12081; TRANSCRIPTION FACTOR E2F; 1.
DR   PANTHER; PTHR12081:SF43; TRANSCRIPTION FACTOR E2F1; 1.
DR   Pfam; PF16421; E2F_CC-MB; 1.
DR   Pfam; PF02319; E2F_TDP; 1.
DR   SMART; SM01372; E2F_TDP; 1.
DR   SUPFAM; SSF144074; E2F-DP heterodimerization region; 1.
DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; DNA-binding; Methylation; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..432
FT                   /note="Transcription factor E2F1"
FT                   /id="PRO_0000219463"
FT   DNA_BIND        108..192
FT                   /evidence="ECO:0000255"
FT   REGION          39..85
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          65..106
FT                   /note="Cyclin A:CDK2 binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   REGION          87..189
FT                   /note="Interaction with BIRC2/c-IAP1"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   REGION          98..126
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          151..172
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   REGION          190..377
FT                   /note="Required for interaction with TRIM28"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   REGION          193..282
FT                   /note="Dimerization"
FT                   /evidence="ECO:0000255"
FT   REGION          297..342
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          363..432
FT                   /note="Transactivation"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   REGION          404..421
FT                   /note="RB1 binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   MOTIF           156..192
FT                   /note="DEF box"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   COMPBIAS        305..321
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         115
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   MOD_RES         118
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   MOD_RES         123
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   MOD_RES         183
FT                   /note="N6-methyllysine; by SETD7"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   MOD_RES         370
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   MOD_RES         398
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
FT   MOD_RES         428
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q01094"
SQ   SEQUENCE   432 AA;  46548 MW;  4E401ADF6E20C13C CRC64;
     MAVAPAGGQH APALEALLGA GALRLLDSSQ IVIISTAPDV GAPQVPTGPA APPAGPRDPD
     VLLFATPQAP RPAPSAPRPA LGRPPVKRRL DLETDHQYLA GSSGPFRGRG RHPGKGVKSP
     GEKSRYETSL NLTTKRFLEL LSHSADGVVD LNWAAEVLKV QKRRIYDITN VLEGIQLIAK
     KSKNHIQWLG SRTMVGIGQR LEGLTQDLQQ LQESEQQLDH LMHICTTQLQ LLSEDSDIQR
     LAYVTCQDLR SIADPAEQMV IVIKAPPETQ LQAVDSAETF QISLKSKQGP IDVFLCPEES
     AEGISPGRTS YQETSGEDRN ADSGTAGPPP SPPSTSPTLD PSQSLLGLEQ EAVLPRIGNL
     RAPMEEDRLS PLVAADSLLE HVKEDFSGLL PGEFISLSPP HEAVDYHFGL EEGEGIRDLF
     DCDFGDLTPL DF
//
